Next, we applied shRNA to knockdown ZEB2 in a RCC cell line to examine its effects on cell migration and invasion and to explore the potential mechanism by which ZEB2 regulates EMT in RCC tissues. This evidence concerns the gene ZEB2 and renal cell carcinoma.